Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Parkinsonism & Related Disorders
|
March 26, 2022
Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum
Matthew Rosebraugh, Sven Stodtmann, Wei Liu, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 22, 2025
Exposure-Response Modeling of Monthly Migraine Days for Efficacy of Atogepant in Patients With Episodic or Chronic Migraine
Louisa Schlachter, Denise Beck, Ramesh R Boinpally, et al.
Journal of Clinical Pharmacology
|
May 29, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine: Analysis of Phase 1-3 Studies
Sven Stodtmann, Lucia Siovitz, Heiko Babel, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 16, 2023
Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK models
Diego Valderrama, Ana Victoria Ponce-Bobadilla, Sven Mensing, et al.
Physical Chemistry Chemical Physics : PCCP
|
August 13, 2015
Parameter-free continuous drift-diffusion models of amorphous organic semiconductors
Pascal Kordt, Sven Stodtmann, Alexander Badinski, et al.
Journal of Clinical Pharmacology
|
November 9, 2019
Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials
Ahmed Nader, Sven Stodtmann, Anna Friedel, et al.
Clinical Pharmacokinetics
|
November 12, 2025
Population Pharmacokinetics of Atogepant for the Prevention of Migraine
Louisa Schlachter, Sven Stodtmann, Alexander Voelkner, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 9, 2025
Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's Disease
Sagar S Bachhav, Ana Victoria Ponce-Bobadilla, Diana Clausznitzer, et al.
Clinical and Translational Science
|
October 28, 2024
Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development
Ana Victoria Ponce-Bobadilla, Vanessa Schmitt, Corinna S Maier, et al.
Clinical and Translational Science
|
August 5, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development
Sumit Bhatnagar, Sven Stodtmann, Yuli Qian, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Parkinsonism & Related Disorders
|
March 26, 2022
Foslevodopa/foscarbidopa subcutaneous infusion maintains equivalent levodopa exposure to levodopa-carbidopa intestinal gel delivered to the jejunum
Matthew Rosebraugh, Sven Stodtmann, Wei Liu, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
November 22, 2025
Exposure-Response Modeling of Monthly Migraine Days for Efficacy of Atogepant in Patients With Episodic or Chronic Migraine
Louisa Schlachter, Denise Beck, Ramesh R Boinpally, et al.
Journal of Clinical Pharmacology
|
May 29, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine: Analysis of Phase 1-3 Studies
Sven Stodtmann, Lucia Siovitz, Heiko Babel, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 16, 2023
Integrating machine learning with pharmacokinetic models: Benefits of scientific machine learning in adding neural networks components to existing PK models
Diego Valderrama, Ana Victoria Ponce-Bobadilla, Sven Mensing, et al.
Physical Chemistry Chemical Physics : PCCP
|
August 13, 2015
Parameter-free continuous drift-diffusion models of amorphous organic semiconductors
Pascal Kordt, Sven Stodtmann, Alexander Badinski, et al.
Journal of Clinical Pharmacology
|
November 9, 2019
Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials
Ahmed Nader, Sven Stodtmann, Anna Friedel, et al.
Clinical Pharmacokinetics
|
November 12, 2025
Population Pharmacokinetics of Atogepant for the Prevention of Migraine
Louisa Schlachter, Sven Stodtmann, Alexander Voelkner, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
May 9, 2025
Use of Model-Based Meta-Analysis to Inform the Design of Early Clinical Trials of Anti-Amyloid Beta Therapies in Alzheimer's Disease
Sagar S Bachhav, Ana Victoria Ponce-Bobadilla, Diana Clausznitzer, et al.
Clinical and Translational Science
|
October 28, 2024
Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development
Ana Victoria Ponce-Bobadilla, Vanessa Schmitt, Corinna S Maier, et al.
Clinical and Translational Science
|
August 5, 2025
Model-Informed Paradigm in Drug Development-An End-To-End Case Study From Upadacitinib Development
Sumit Bhatnagar, Sven Stodtmann, Yuli Qian, et al.
Page
of 3